Show Summary Details
Page of

SALL1 and the Townes-Brocks Syndrome 

SALL1 and the Townes-Brocks Syndrome
Chapter:
SALL1 and the Townes-Brocks Syndrome
Author(s):

Jürgen Kohlhase

, Rosa Barrio

, and James D. Sutherland

DOI:
10.1093/med/9780199934522.003.0033
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 09 March 2021

Townes–Brocks syndrome (TBS, MIM 107480) is a rare autosomal dominantly inherited malformation syndrome characterized by anal, renal, limb, and ear anomalies. TBS results from mutations in SALL1, a human gene related to the developmental regulator sal of Drosophila melanogaster. The SALL1 gene product is a zinc finger protein thought to act as a transcription factor. It contains four highly conserved C2H2 double zinc finger domains, which are evenly distributed. The protein is exclusively found in the nucleus and localizes to pericentromeric heterochromatin. SALL1 acts as a transcriptional repressor and contains two repression domains, but SALL1 orthologues can also activate expression of target genes. Nearly all known mutations within the SALL1 gene are located in exon 2. These are nonsense mutations (one of which causes TBS in nearly half of the sporadic cases), short insertions, duplications, and deletions as well as one large intra-exonic deletion. One mutation within intron 2 creates an aberrant splice site. All mutations lead to pre-terminal stop codons. The detection of whole gene deletions in TBS patients proved that SALL1 haploinsufficiency is clearly involved in the pathogenesis of TBS, which is contrary to the observations in Sall1 mouse mutants. The presumably more severe TBS phenotype associated with truncating SALL1 mutations, as compared to larger deletions, however, indicates an additional dominant-negative action of nonfunctional truncated SALL1 proteins.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.